A23L 33/127
Antibiotics
Official title: {Antibiotics}
A23L33/127 (Antibiotics) appears on 45 US grants and 77 published applications in this corpus.
Search patents in A23L- Granted patents
- 45
- Published applications
- 77
- Assignees
- 45
- Inventors
- 165
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 4 |
| 2006 | 2 | 1 |
| 2007 | 0 | 6 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 2 |
| 2012 | 2 | 1 |
| 2013 | 1 | 1 |
| 2014 | 2 | 3 |
| 2015 | 1 | 3 |
| 2016 | 1 | 5 |
| 2017 | 2 | 4 |
| 2018 | 2 | 4 |
| 2019 | 4 | 9 |
| 2020 | 6 | 6 |
| 2021 | 2 | 10 |
| 2022 | 7 | 6 |
| 2023 | 1 | 5 |
| 2024 | 6 | 0 |
| 2025 | 2 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods of controlling pests28 Apr 2026US 12,610,957 B2Pertinent Eco-Solutions Inc.
- Methods for recovering organic acids or salts or lactones thereof from aqueous solutions using water solvent crystallization and compositions thereof23 Dec 2025US 12,503,421 B2Danisco US Inc.
- Use of a lignin fraction as a human and animal food supplement ingredient17 Jun 2025US 12,329,725 B2Green Innovation GmbH
- Pathogenic bacteria24 Dec 2024US 12,171,734 B2Sporegen Limited
- Nitroimidazole formulations24 Dec 2024US 12,171,748 B2IRP Health Pty Ltd
- Synergistic bacterial compositions and methods of production and use thereof27 Feb 2025US 2025/0064869 A1Seres Therapeutics, Inc.
- Nitroimidazole formulations30 Jan 2025US 2025/0032455 A1
- Compositions Comprising (Bio)-Alkanediols with Antimicrobials for Product Protection16 Nov 2023US 2023/0364027 A1Symrise AG
- Compositions Comprising (Bio)-Alkanediols with Antimicrobials for Product Protection21 Sep 2023US 2023/0293407 A1Symrise AG
- Novel antibacterial peptide and use thereof14 Sep 2023US 2023/0287044 A1Anygen Co., Ltd.
Most cited
By later US patents
- Synergistic bacterial compositions and methods of production and use thereof242US 9,028,841 B2Seres Health, Inc. · 2015
- Synergistic bacterial compositions and methods of production and use thereof138US 8,906,668 B2Seres Health, Inc. · 2014
- Synergistic bacterial compositions and methods of production and use thereof78US 9,533,014 B2Seres Therapeutics, Inc. · 2017
- Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections25US 7,033,997 B2Pharis Biotec GmbH · 2006
- Synergistic bacterial compositions and methods of production and use thereof21US 10,864,235 B2Seres Therapeutics, Inc. · 2020